Teladoc Health (TDOC) Receivables - Other (2014 - 2026)

Teladoc Health (TDOC) has 7 years of Receivables - Other data on file, last reported at $8.9 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 13.17% year-over-year to $8.9 million; the trailing twelve-month figure through Mar 2026 stood at $8.9 million (down 13.17% YoY), and the FY2025 full-year result was $8.8 million, down 9.94% from the prior year.
• Receivables - Other advanced to $8.9 million in Q1 2026, from $8.8 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $25.1 million in Q1 2023 to a low of $8.6 million in Q2 2025.
• A 5-year average of $14.6 million and a median of $12.3 million in 2023 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other advanced 18.53% in 2022 and sank 49.62% in 2023, its largest moves.
• Tracing TDOC's Receivables - Other over 5 years: stood at $25.1 million in 2022, then slumped by 49.62% to $12.6 million in 2023, then decreased by 22.4% to $9.8 million in 2024, then decreased by 9.94% to $8.8 million in 2025, then increased by 0.87% to $8.9 million in 2026.
• Business Quant data shows TDOC's Receivables - Other at $8.9 million in Q1 2026, $8.8 million in Q4 2025, and $8.7 million in Q3 2025.